Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Industrials · Services-Help Supply Services

Aya Healthcare to acquire Cross Country Healthcare Inc

Announced Dec 4, 2024 · Terminated

Deal value$615M
Premium67.0%To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash$18.61 per share

Transaction

Acquirer
Aya Healthcare
Target
Cross Country Healthcare Inc (CCRN)
Buyer type
Strategic
Offer price per share
$18.61
Enterprise value
—
Status
Terminated

Deal protections

Break fee (target pays)
$20.0M · 3.3%
Reverse fee (buyer pays)
$20.0M · 3.3%
Go-shop
No-shop
Financing
No financing condition

Advisors

To the acquirer
Not disclosed
To the target
BofA Securities

Sector context · Industrials

Comparable deals
87 in the prior 24 months
Premium
67.0% vs. 34.0% sector median
EV / Adj. EBITDA
Sector median 9.4x
Break fee
3.3% vs. 2.8% sector median

Timeline

  1. AnnouncedDec 4, 2024
  2. Proxy filedJan 6, 2025
  3. Definitive proxyJan 22, 2025
  4. Shareholder voteFeb 28, 2025
  5. Terminated—
Sources
  • 8-K (EX-99) · Dec 4, 2024
  • DEFA14A (EX-99.1) · Dec 4, 2024
  • 8-K · Dec 4, 2024

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.